The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics
Affiliations
- PMID: 7979046
Item in Clipboard
The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics
Ann Plast Surg.
1994 Aug.
No abstract available
Similar articles
-
Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts.Ann Plast Surg. 1994 Aug;33(2):148-51. doi: 10.1097/00000637-199408000-00005. Ann Plast Surg. 1994. PMID: 7979045
-
Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.Acta Derm Venereol. 2005;85(3):216-20. doi: 10.1080/00015550410025453. Acta Derm Venereol. 2005. PMID: 16040405
-
Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.Acta Derm Venereol. 2006;86(4):300-7. doi: 10.2340/00015555-0101. Acta Derm Venereol. 2006. PMID: 16874413
-
The molecular basis of keloid and hypertrophic scar formation.Mol Med Today. 1998 Jan;4(1):19-24. doi: 10.1016/S1357-4310(97)80541-2. Mol Med Today. 1998. PMID: 9494966 Review.
-
The pathogenesis of hypertrophic/keloid scarring.Int J Oral Maxillofac Surg. 1994 Aug;23(4):232-6. doi: 10.1016/s0901-5027(05)80377-7. Int J Oral Maxillofac Surg. 1994. PMID: 7798696 Review.
Cited by
-
Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.Am J Pathol. 2003 May;162(5):1579-89. doi: 10.1016/S0002-9440(10)64292-7. Am J Pathol. 2003. PMID: 12707042 Free PMC article.
-
Regulation of Transforming Growth Factor β1, Platelet-Derived Growth Factor, and Basic Fibroblast Growth Factor by Silicone Gel Sheeting in Early-Stage Scarring.Arch Plast Surg. 2015 Jan;42(1):20-7. doi: 10.5999/aps.2015.42.1.20. Epub 2015 Jan 14. Arch Plast Surg. 2015. PMID: 25606485 Free PMC article.
-
Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity.J Invest Dermatol. 2014 Jul;134(7):2041-2043. doi: 10.1038/jid.2014.71. Epub 2014 Feb 4. J Invest Dermatol. 2014. PMID: 24496234 No abstract available.
-
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars.J Immunol Res. 2020 Jan 7;2020:7057195. doi: 10.1155/2020/7057195. eCollection 2020. J Immunol Res. 2020. PMID: 32377536 Free PMC article.
-
Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.J Am Coll Clin Wound Spec. 2013 Jul 1;4(2):23-31. doi: 10.1016/j.jccw.2013.06.001. eCollection 2012 Jun. J Am Coll Clin Wound Spec. 2013. PMID: 24936445 Free PMC article.